We have done it! SaxoCell will continue into phase 2 of the Clusters4Future initiative!

We thank everyone involved in our application! Your expertise, innovation and commitment have been the driving force behind our success.

As we move into the next phase, our focus will remain on pushing the boundaries of what is possible in the field of cell and gene therapy. Let’s continue to work closely to achieve the ambitious goals we have set. Together, we will transform ideas into reality, bringing cutting-edge therapies from labs to clinic.

The SaxoCell Hub will transform into SaxoCellutions. We look forward to carry on and will contiune to offer workshops, training courses and networking events as well as to support all SaxoCell projects.

What is the focus of your current research and what aspects are you interested in?
My research focuses on editing the epigenome to reprogram immune cells, especially for the advancement of allogeneic CAR T cell therapy. I am very intrigued by this work, because it combines the most cutting-edge aspects from cell therapy, as well as genetic engineering, in order to generate safer cell therapies with high efficacy.

Please finish the following sentence: SaxoCell is …
SaxoCell is giving young researchers the opportunity to conduct research with the potential for serious impact on the development and translation of gene and cell therapies in Saxony and beyond.

Outside of academics, what are some of your hobbies or interests?
I am part of the university Dresden’s Handball team and generally enjoy doing sports and outdoor activities as a balance to the lab and office work.

What is one technology or innovation that you could not live without?
Digital, shareable & synchronizable calendars to organize my life.

If you could have a superpower, what would it be and why?
A photographic / super memory but with the option to forget unpleasant experiences.

Looking ahead ten years, what discovery, invention, or insight would you like to witness?
Considering the exponential advancements in genetic engineering since the first created recombinant DNA, roughly 50 years ago. I am super excited what humanity will be able to build with genes in the next 10-20 years, especially regarding species revival and synthetic life.

Where would you travel to if there was a time machine?
The Jurassic Period (except we created Dinosaur-like creatures before the time machine invention)

What if your lab had its own barista? Which coffee creation would you order regularly?
Italian Caffè Macchiato

Nature (8 Jul 2024) --- A recent study published in Bone Marrow Transplantation explores the effectiveness of post-transplant cyclophosphamide (PTCy) compared to anti-thymocyte globulin (ATG) in reducing acute graft-versus-host disease (aGVHD) in higher-risk myelodysplastic syndrome (MDS) patients. The research indicates that PTCy is associated with a lower incidence of acute GVHD compared to ATG, specifically in cases of allogeneic hematopoietic cell transplantation. This suggests PTCy may be a more favorable option for GVHD prophylaxis in patients with higher-risk MDS undergoing transplantation.

CAR T Reduces All-Cause Mortality Greater Than a Bispecific Antibody in MM
(Sep 13, 2024)

VaxCell-Bio partners with ProBio to accelerate CAR-related therapies development
(Sep 9, 2024)

Leukemia Therapeutics Market 26481.60mn Size, Consumer Behavior and Market Evolution 2024-2032
(Sep 7, 2024)

Our speakers provided valuable insights and practical knowledge, offering a glimpse into exciting new applications. Both in-person and online participants engaged in lively discussions - whether during the ice cream breaks or at the conclusion of each session.

Our event brought together a diverse group, including prominent speakers such as Ivan Đikić from Goethe University Frankfurt, Ulrike Köhl from Fraunhofer IZI & Leipzig University, Frank Buchholz from TU Dresden, and Martin Bornhäuser from Universitätsklinikum Carl Gustav Carus Dresden.

Scientists, industry representatives, and our cluster management teams had the chance to exchange ideas and insights, paving the way for future cooperation.

A heartfelt thank you to everyone who contributed to this important networking event. We are excited to continue this format and look forward to the innovations and partnerships that will emerge from it!

During the engaging presentations, the unique nature of patents in the life sciences sector was thoroughly explored. To round off the day, participants had the opportunity to discuss their own inventions in one-on-one sessions with the patent attorneys, making it an invaluable learning experience for all.

We thank everyone involved and look forward to continuing this important conversation in future workshops!

For the third time, all future clusters of the first and second round had the opportunity to share their experience and to talk directly with representatives BMBF and PtJ. The cluster meeting in Munich offered participants from various future clusters a valuable platform for exchange and networking.

On day one, the CNATM future cluster welcomed us to LMU Munich. After a relaxed get-together with lunch, the clusters presented their challenges for ‘Securing skilled workers, recruiting young talent & Co’. The six short impulses in particular stimulated intensive discussions. After the coffee break, a speed dating round encouraged networking across cluster boundaries. The exciting insight into the work of the CNATM provided new perspectives. The day ended with a cosy get-together over dinner at Gasthaus Erdinger.

The second day of the event in the TUM's Vorhoelzer Forum kicked off with coffee and lively discussions. MCube gave an impressive presentation of its projects, followed by an exciting short talk by Dr Julia Schaft, who also took part in the lively panel discussion. The exchange ended with lunch-to-go, which meant that the participants left with new impulses and contacts. Overall, the event encouraged the exchange of ideas and collaboration between the clusters, further increasing the anticipation of future meetings.

If you are interested in more information about any of these events or about the role of SaxoCell at these conferences, please do not hesitate to contact us.